Investors in Bicycle Therapeutics (NASDAQ:BCYC) From Three Years Ago Are Still Down 72%, Even After 5.4% Gain This Past Week

Simply Wall StJan 6 08:44 ET

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireJan 3 16:05 ET

First Solar, Frontier Communications, and More Stocks See Action From Activist Investors -- Barrons.com

Barron'sDec 20, 2024 15:27 ET

Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday

BenzingaDec 18, 2024 10:20 ET

JMP Securities Maintains Bicycle Therapeutics(BCYC.US) With Buy Rating, Cuts Target Price to $26

Moomoo NewsDec 18, 2024 01:31 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Century Therapeutics (IPSC), Incyte (INCY) and Bicycle Therapeutics (BCYC)

TipRanksDec 18, 2024 00:40 ET · Ratings